New drug could slow tumour regrowth in inoperable bowel cancer

Adavosertib found to delay tumour growth in some patients in clinical trial, with few side effects

Researchers have identified a potential new targeted treatment for incurable bowel cancer.

The medication has shown promise in a clinical trial in slowing the regrowth of tumours among some patients with the condition.